BioPerfectus introduces our Cervical Cancer Screening Solution, featuring the Globally Exclusive Commercial Used Technology: 21 Type-Specific Normalized Viral Load. It integrates HPV genotyping with Normalized viral load determination for precise identification of high-grade lesions in HPV-positive cases.

Key Features:

1. Validated for high sensitivity and specificity, ensuring trustworthy results.
2. Flexible Operations: Features a walk-away system from VTM to PCR tubes, with one software for amplification, interpretation, and customized reports.
3. Consistent with the principle of a single-visit approach, reducing losses due to triage and follow-up with higher cost efficiency.